Skip to main contentAll experts

Matthew Cascio

CLIN AST PROF

MD-PEDIATRICS

  • CLIN AST PROF
    MD-PEDIATRICS

GRANTS

  • GRANT
    LOGGIC/FIREFLY-2: A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
    Day One Biopharmaceuticals15 Nov 2024 - 14 Nov 2029
    Active
  • GRANT
    CART Cells for Sarcoma
    Sarcoma Foundation of America1 Jun 2017 - 31 May 2019
    People funded by this grant:
  • GRANT
    An Immunological Strategy to Osteosarcoma: Reconditioning the Immune System with Adoptive CAR-T Cells and Reversal of Regulatory Pathways.
    Hyundai Hope On Wheels21 Apr 2017 - 31 Aug 2021
    Expired
  • GRANT
    CART Cells for Sarcoma
    SARComa Foundation of America6 Apr 2017 - 30 Apr 2019
    Expired